GlassScriptPhysician profile
Jorge L Serrat
NPI 1497810949
$2,441.23
in general payments reported to CMS, 2019-2025
8 companies · $454 in 2025
The $454 reported for 2025 was more than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $124 · 2020: $154 · 2021: $190 · 2022: $482 · 2023: $585 · 2024: $452 · 2025: $454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,492.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,491.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $975.69 | 2019-2025 | Lupron Depot, Synthroid |
| Amneal Pharmaceuticals LLC | $558.14 | 2021-2025 | Unithroid |
| Novo Nordisk INC | $509.11 | 2019-2024 | Sogroya, Norditropin |
| Pfizer INC. | $126.42 | 2023-2025 | |
| Ascendis Pharma Endocrinology INC | $105.90 | 2022 | |
| Ge Healthcare | $75.00 | 2024 | |
| Sandoz INC. | $72.90 | 2019-2025 | Omnitrope |
| Ferring Pharmaceuticals INC. | $18.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jorge Serrat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.